73 min listen
Ep. 255: “Pathway to the Clinic” Featuring Drs. Stefan Irion and Viviane Tabar
Ep. 255: “Pathway to the Clinic” Featuring Drs. Stefan Irion and Viviane Tabar
ratings:
Length:
65 minutes
Released:
Nov 14, 2023
Format:
Podcast episode
Description
Dr. Stefan Irion is the Chief Scientific Officer of BlueRock Therapeutics and Dr. Viviane Tabar is the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center. In this special episode, recorded in front of a live audience in New York, they talk about their work on BlueRock's clinical trial for bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson's disease. They also discuss what's next for cell therapy and diversity in science and in patients.
Released:
Nov 14, 2023
Format:
Podcast episode
Titles in the series (100)
Ep. 18: Lou Gehrig’s Update Featuring Dr. Kevin Eggan: Guest Dr. Kevin Eggan from Harvard University joins the show to talk about his latest work using stem cells to cure ALS/Lou Gehrig’s disease. Resources and Links Fate of iPSCs Derived from Azoospermic and Fertile… by The Stem Cell Podcast